Pediatric endocrinology

Premature pubarche in Prader‐Willi syndrome: Risk factors and consequences

Clin Endocrinol (Oxf)Published Retrospective cohort study

Authors' conclusion

PP is common in PWS but does not compromise final height in comparison to the NP group. Obesity and insulin resistance were not associated with PP in children with PWS, contrary to what has been seen in obese children without PWS.

Study context

Population
Children with Prader-Willi syndrome treated at one institution, 1990–2021
Participants
43 children
Exposure
Prader-Willi Syndrome (PWS) with premature pubarche vs normal pubarche
  • Premature pubarche (PP)n = 23
  • Normal pubarche (NP)n = 20reference
Outcome
Frequency of PP, and its potential precursors and sequelae, in PWS
Methodological detailschart review, single-centre
  • Chart review
  • Single-centre

Main finding

As reported in the abstract

Frequency of PP

Observational data: associations, not effects.

Further findings

Age at pubarche

HDL · lower HDL with PP

P = 0.041

Difference between target and final height · did not differ
P = 0.507

Age at pubarche

Age at pubarche not correlated with age of recombinant human growth hormone (rhGH) initiation, body mass index (BMI) z-score or homeostasis model assessment of insulin resistance (HOMA-IR) at pubarche

BMI z-score at pubarche vs degree of pubarchal BA advancement

Modestly correlated
P = 0.033

Original publication

Premature pubarche in Prader‐Willi syndrome: Risk factors and consequences. Clin Endocrinol (Oxf). Published 27 June 2024. doi:10.1111/cen.15108

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.